U.S. Long-acting Contraception Market Size, Share & Trends Analysis Report By Product (Intrauterine Devices, Subdermal Implants, Injectables), And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market Segmentation & Scope
                      1.1.1 Estimates And Forecast Timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                      1.3.1 Purchased Database
                      1.3.2 Gvr’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details Of Primary Research
                 1.4 Information Or Data Analysis
                      1.4.1 Data Analysis Models
                 1.5 Market Formulation & Validation
                 1.6 Model Details
                      1.6.1 Commodity Flow Analysis
                 1.7 List Of Secondary Sources
                 1.8 List Of Abbreviations
                 1.9 Objectives
                      1.9.1 Objective 1
                      1.9.2 Objective 2
                      1.9.3 Objective 3
Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Segment Outlook
                      2.2.1 Product
                 2.3 Competitive Insights
Chapter 3 Market Variables, Trends, & Scope
                 3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Related/Ancillary Market Outlook
                 3.2 Market Dynamics
                      3.2.1 Market Driver Analysis
                            3.2.1.1 Increasing Adoption Of Long-Acting Contraceptives
                            3.2.1.2 Strong Government Support
                            3.2.1.3 Rising Publicly Funded Family Planning Services
                      3.2.2 Market Restraint Analysis
                            3.2.2.1 Less Approved Products
                            3.2.2.2 Adverse Side Effects Associated With Use Of Larc
                 3.3 Business Environment Analysis Tools
                      3.3.1 Pestle Analysis
                            3.3.1.1 Political & Legal Landscape
                            3.3.1.2 Economic & Social Landscape
                            3.3.1.3 Technological Landscape
                      3.3.2 Porter’s Five Forces Analysis
                            3.3.2.1 Competitive Rivalry: Moderate
                            3.3.2.2 Bargaining Power Of Suppliers: Moderate
                            3.3.2.3 Bargaining Power Of Buyers: High
                            3.3.2.4 Threat Of New Entrants: High
                            3.3.2.5 Threat Of Substitutes: Moderate
                 3.4 Penetration & Growth Prospect Mapping
                 3.5 Regulatory Framework And Reimbursement Analysis
                      3.5.1 Regulatory Scenario
                      3.5.2 Reimbursement Framework
                 3.6 Impact of COVID-19: Qualitative Analysis
                 3.7 Demographic Analysis: Methods of Contraception, 2019
Chapter 4 U.S. Long-acting Contraception Market: Product Analysis
                 4.1 U.S. Long-acting Contraception Market Share analysis, 2020 & 2028
                 4.2 Segment Dashboard
                 4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Product
                      4.3.1 Intrauterine Devices (IUD)
                            4.3.1.1 Intrauterine Devices (IUD) market, 2016 - 2028 (USD Million)
                            4.3.1.2 Hormonal IUD
                                  4.3.1.2.1 Hormonal IUD market, 2016 - 2028 (USD Million)
                            4.3.1.3 Nonhormonal IUD
                                  4.3.1.3.1 Nonhormonal IUD market, 2016 - 2028 (USD Million)
                      4.3.2 Subdermal Implants
                            4.3.2.1 Subdermal Implants market, 2016 - 2028 (USD Million)
                      4.3.3 Injectable 
                            4.3.3.1 Injectable market, 2016 - 2028 (USD Million)
Chapter 5 Competitive Analysis
                 5.1 Recent Developments & Impact Analysis, by Key Market Participants
                 5.2 Competition Categorization
                 5.3 Company Market Position Analysis
                 5.4 Company Profiles
                      5.4.1 MERCK & CO., INC.
                            5.4.1.1 Company overview
                            5.4.1.2 Financial performance
                            5.4.1.3 Product benchmarking
                            5.4.1.4 Strategic initiatives
                            5.4.1.5 SWOT analysis
                      5.4.2 PFIZER INC.
                            5.4.2.1 Company overview
                            5.4.2.2 Financial performance
                            5.4.2.3 Product benchmarking
                            5.4.2.4 SWOT analysis
                      5.4.3 THE COOPER COMPANIES INC.
                            5.4.3.1 Company overview
                            5.4.3.2 Financial performance
                            5.4.3.3 Product benchmarking
                            5.4.3.4 Strategic initiatives
                            5.4.3.5 SWOT analysis
                      5.4.4 ALLERGAN (ABBVIE INC.)
                            5.4.4.1 Company overview
                            5.4.4.2 Financial performance
                            5.4.4.3 Product benchmarking
                            5.4.4.4 Strategic initiatives
                            5.4.4.5 SWOT analysis
                      5.4.5 BAYER AG
                            5.4.5.1 Company overview
                            5.4.5.2 Financial performance
                            5.4.5.3 Product benchmarking
                            5.4.5.4 Strategic initiatives
                            5.4.5.5 SWOT analysis
Chapter 6 KOL Comments

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Long-acting contraceptives and associated adverse effects
TABLE 4 Classification of contraceptives by the U.S. FDA
TABLE 5 States that have expanded on contraceptive coverage guarantee in Affordable Care Act
TABLE 6 List of intrauterine devices currently available in the U.S.

List of Figures

FIG. 1 U.S. long-acting contraception market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2020 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Percentage of women (aged 15-49) using modern contraceptive methods in U.S., 2019
FIG. 15 Percentage of women (aged 15-49) using traditional contraceptive methods in U.S., 2019
FIG. 16 U.S. long-acting contraception market: Product movement analysis (USD Million)
FIG. 17 U.S. long-acting contraception treatment outlook: Key takeaways (USD Million)
FIG. 18 Intrauterine devices (IUD) market, 2016 - 2028 (USD Million)
FIG. 19 Hormonal IUD market, 2016 - 2028 (USD Million)
FIG. 20 Nonhormonal IUD market, 2016 - 2028 (USD Million)
FIG. 21 Subdermal implants market, 2016 - 2028 (USD Million)
FIG. 22 Injectable market, 2016 - 2028 (USD Million)
FIG. 23 Recent development & impact analysis by key market participants
FIG. 24 Competition categorization
FIG. 25 Company market position analysis